BIOSTAR CAPITAL
BioStar Ventures is a venture capital company that offers private equity investment services to firms in the medical device technology services industries. It was founded in 2003 by Louis Cannon and is based in Michigan.
BIOSTAR CAPITAL
Social Links:
Industry:
Angel Investment Finance Venture Capital
Founded:
2003-01-01
Status:
Active
Contact:
231 487 9183
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Google Cloud Google Cloud Iowa
Similar Organizations
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Advisors List
Carl Deirmengian Scientific Advisor @ BioStar Capital Advisor 2011-01-01
Current Employees Featured
Steven L. Almany
Steven L. Almany Managing Director @ BioStar Capital Managing Director 2005-01-01
Paul Scott
Paul Scott Chief Financial Officer @ BioStar Capital Chief Financial Officer
Lisa Riedmiller
Lisa Riedmiller Controller @ BioStar Capital Controller
David J. Brophy
David J. Brophy Director @ BioStar Capital Director
Renee Masi
Renee Masi Managing Director @ BioStar Capital Managing Director 2006-06-01
Tracy Lockwood
Tracy Lockwood Executive Assistant @ BioStar Capital Executive Assistant
Louis Cannon
Louis Cannon Founder & Senior Managing Director @ BioStar Capital Founder & Senior Managing Director 2003-06-01
Mark Toland
Mark Toland Partner and EIR @ BioStar Capital Partner and EIR 2020-07-01
Hank Kucheman
Hank Kucheman Director @ BioStar Capital Director 2014-01-01
Founder
Louis Cannon
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-09 | REVA Medical | BioStar Capital investment in Series B - REVA Medical | 45 M USD |
2022-07-20 | MMI | BioStar Capital investment in Series B - MMI | 75 M USD |
2022-06-13 | Ablative Solutions | BioStar Capital investment in Series D - Ablative Solutions | 91.4 M USD |
2020-06-22 | Foldax | BioStar Capital investment in Series D - Foldax | 20 M USD |
2020-02-25 | Aria CV | BioStar Capital investment in Series B - Aria CV | 31 M USD |
2019-02-26 | Corindus | BioStar Capital investment in Post-IPO Equity - Corindus | 19.5 M USD |
2019-01-14 | Trice Medical | BioStar Capital investment in Series C - Trice Medical | 18.3 M USD |
2019-01-03 | Ablative Solutions | BioStar Capital investment in Series D - Ablative Solutions | 77 M USD |
2018-04-27 | V-Wave | BioStar Capital investment in Series C - V-Wave | 70 M USD |
2018-03-16 | Corindus | BioStar Capital investment in Post-IPO Equity - Corindus | 25 M USD |